See more : Design Capital Limited (1545.HK) Income Statement Analysis – Financial Results
Complete financial analysis of Branded Legacy Inc (BLEG) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Branded Legacy Inc, a leading company in the Packaged Foods industry within the Consumer Defensive sector.
You may be interested
- PowerUp Acquisition Corp. (PWUPW) Income Statement Analysis – Financial Results
- Elevate Credit, Inc. (0XWD.L) Income Statement Analysis – Financial Results
- Air Transport Services Group, Inc. (ATSG) Income Statement Analysis – Financial Results
- Tokai Carbon Co., Ltd. (5301.T) Income Statement Analysis – Financial Results
- Revivegen Co., Ltd. (7578.TWO) Income Statement Analysis – Financial Results
Branded Legacy Inc (BLEG)
About Branded Legacy Inc
Branded Legacy Inc engages in the commercial development of hemp and cannabinoid-infused beverages in Central Florida. It provides CBD topicals and tinctures, and hemp coffees and teas. The company was formerly known as Elev8 Brands, Inc. and changed its name to Branded Legacy Inc in May 2020. Branded Legacy Inc is headquartered in Longwood, Florida.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 82.91K | 215.53K | 64.26K | 100.63K | 604.50K | 372.31K | 144.76K | 191.00 | 16.90K |
| Cost of Revenue | 265.00 | 72.62K | 33.19K | 77.98K | 236.61K | 159.46K | 69.29K | 0.00 | 8.24K |
| Gross Profit | 82.64K | 142.91K | 31.07K | 22.65K | 367.89K | 212.84K | 75.47K | 191.00 | 8.66K |
| Gross Profit Ratio | 99.68% | 66.31% | 48.35% | 22.51% | 60.86% | 57.17% | 52.14% | 100.00% | 51.25% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 252.29K | 244.12K | 682.19K | 477.53K | 158.24K | 364.00 | 76.48K |
| Selling & Marketing | 0.00 | 0.00 | 92.59K | 76.99K | 136.74K | 103.13K | 42.70K | 0.00 | 0.00 |
| SG&A | -3.74M | 306.61K | 344.87K | 321.11K | 818.92K | 580.66K | 200.93K | 364.00 | 76.48K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -30.00 | -171.00 |
| Operating Expenses | -3.74M | 306.61K | 344.87K | 321.11K | 818.92K | 580.66K | 200.93K | 364.00 | 76.48K |
| Cost & Expenses | -3.74M | 379.23K | 378.06K | 399.09K | 1.06M | 740.12K | 270.22K | 364.00 | 84.72K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 42.00 | 0.00 |
| Depreciation & Amortization | 167.90K | 20.63K | 236.56K | 3.61K | 3.59K | 3.54K | 52.52K | 22.82K | 250.00 |
| EBITDA | 3.83M | -143.07K | -313.80K | -294.85K | -2.05M | -364.27K | -125.46K | -173.00 | -67.57K |
| EBITDA Ratio | 4,614.24% | -66.39% | -488.37% | -293.01% | -74.61% | -97.84% | -86.67% | -90.58% | -399.80% |
| Operating Income | 3.83M | -163.70K | -313.80K | -298.46K | -451.03K | -367.82K | -125.46K | -173.00 | -67.82K |
| Operating Income Ratio | 4,614.24% | -75.95% | -488.37% | -296.61% | -74.61% | -98.79% | -86.67% | -90.58% | -401.28% |
| Total Other Income/Expenses | 0.00 | -1.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -72.00 | -369.00 |
| Income Before Tax | 3.83M | -163.70K | -313.80K | -298.46K | -451.03K | -367.82K | -125.46K | -245.00 | -68.19K |
| Income Before Tax Ratio | 4,614.24% | -75.95% | -488.37% | -296.61% | -74.61% | -98.79% | -86.67% | -128.27% | -403.47% |
| Income Tax Expense | -167.90K | -5.00 | -236.56K | -1.00 | -1.61M | -157.60K | -52.52K | -22.77K | 198.00 |
| Net Income | 3.83M | -163.70K | -313.80K | -298.46K | -451.03K | -367.82K | -125.46K | -245.00 | -68.19K |
| Net Income Ratio | 4,614.24% | -75.95% | -488.37% | -296.61% | -74.61% | -98.79% | -86.67% | -128.27% | -403.47% |
| EPS | 0.01 | 0.00 | -0.17 | -0.01 | -0.24 | -0.26 | -0.07 | 0.00 | 0.00 |
| EPS Diluted | 0.01 | 0.00 | -0.17 | -0.01 | -0.24 | -0.25 | -0.07 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 295.00M | 227.85M | 1.90M | 50.14M | 1.90M | 1.44M | 1.93M | 2.29M | 0.00 |
| Weighted Avg Shares Out (Dil) | 295.00M | 227.85M | 1.90M | 50.14M | 1.90M | 1.48M | 1.93M | 2.29M | 0.00 |
Branded Legacy, Inc. Secures Key Client with $70,000,000 Annual Revenue; Expects to Surpass $10,000,000 in 2025
500% Growth Target Has Been Set For The Next Six Months of Operations MELBOURNE, Fla. , Oct. 1, 2024 /PRNewswire/ -- Branded Legacy, Inc.,(OTC.PK: BLEG) a leading supplier of botanical extracts and alkaloid-based compounds, is excited to announce that it has...
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing
MELBOURNE, Fla. , June 27, 2024 /PRNewswire/ -- Branded Legacy, Inc. (OTC.PK: BLEG), a leading manufacturer of wellness products, is thrilled to announce a new strategic partnership with Hemp Emu, a renowned provider of premium CBD products.
Branded Legacy Secures Exclusive Extraction Partnership with One of the World's Largest Kava Distributors and Producers
Extraction agreement with Botany Evolution LLC to generate over $1 Million in annual profits MELBOURNE, Fla. , May 30, 2024 /PRNewswire/ -- Branded Legacy, Inc. (OTC.PK: BLEG) a leading innovator in kava extraction and formulation, is pleased to announce an exclusive...
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product
MELBOURNE, Fla. , May 22, 2024 /PRNewswire/ -- Branded Legacy, Inc. (OTCPK: BLEG), a leading provider of innovative wellness and skincare products, is thrilled to announce its exciting collaboration with renowned celebrity tattoo artist Katrina "Kat Tat" Collins for the creation...
Branded Legacy Inc. Invites Shareholders to Celebrate Milestones at Open House: Announces Share Buyback and Commitment to Authorized Share Count
Leading Cannabis Innovator Demonstrates Confidence in Future Growth and Shareholder Value MELBOURNE, Fla. , May 15, 2024 /PRNewswire/ -- Branded Legacy, Inc, (OTCQB: BLEG) a leading provider of innovative wellness products, is thrilled to announce a momentous occasion for the...
Branded Legacy, Inc. Reports Significant Net Income of Over $3.8 Million
Growth and Strategic Expansions in 2024 With Over $3.7 Million In Assets MELBOURNE, Fla. , April 16, 2024 /PRNewswire/ -- Branded Legacy, Inc, (OTC.PK: BLEG) a leading provider of innovative wellness products, is pleased to announce a net income for...
Branded Legacy, Inc. To Add $320,000 In Revenue With New White Label Contract
Royal Biotek Enhances Everglade Line with New Products MELBOURNE, Fla. , April 9, 2024 /PRNewswire/ -- Royal Biotek, a subsidiary of Branded Legacy, Inc. (Symbol: $BLEG), is proud to announce the expansion of its Everglade line, a distinguished collection of...
Branded Legacy, Inc Announces White Label Deal with Kava & Hobbs, LLC for Kava Vape formulation
Branded Legacy, Inc Announces White Label Deal with Kava & Hobbs, LLC for Kava Vape formulation "Branded Legacy Strengthens Relationship with Surge Distribution Company, bolstering quarter 1 revenue" MELBOURNE, Fla. , April 4, 2024 /PRNewswire/ -- Branded Legacy, Inc, (OTC.PK:...
Branded Legacy, Inc. Significantly Expands Asset Portfolio and Production Capacity Through Successful Acquisition of Sycamore BioPharma, Inc.
"Company Prepares for Clinical Trials with Esteemed Addition: Dr. Mark T. Hamann, Endowed Chair of Drug Discovery and Biomedical Sciences at the MUSC College of Pharmacy" MELBOURNE, Fla.
Branded Legacy, Inc. Strengthens Position in BioTech Industry with Letter of Intent to Purchase Sycamore BioPharma, LLC
The Company will secure over 2 Million in assets as well as personnel necessary for clinical trials in upcoming acquisition MELBOURNE, Fla. , Feb. 29, 2024 /PRNewswire/ -- Branded Legacy (OTC.PK: BLEG), Inc., a leading BioTech holdings company, announced today the ...
Source: https://incomestatements.info
Category: Stock Reports